Usage Examples
- We filed an Abbreviated 510(k) and declared conformity to the recognized biocompatibility standard rather than writing up the cytotoxicity comparison ourselves.
- No recognized reference covers that performance question, so the Abbreviated 510(k) route is closed and we file Traditional.
- The reviewer rejected the Abbreviated 510(k) declaration because we conformed to a superseded edition of the standard.
What is Abbreviated 510(k)?
Abbreviated 510(k) is a premarket notification format in which conformance to an FDA-recognized consensus standard, special control, or guidance document substitutes for the device-by-device test summaries a Traditional 510(k) requires.
Abbreviated 510(k) exists because most of the performance questions in a premarket notification have already been answered once, at the standard-setting level. Congress gave FDA authority to recognize consensus standards and to accept a declaration of conformity against them, so a submitter can point at the recognized standard instead of re-arguing biocompatibility or electrical safety device by device.
Abbreviated 510(k) covers the presentation of performance evidence, not the substance of the decision. Everything a Traditional 510(k) owes still applies: intended use, labeling, the comparison to a legally marketed predicate, and a 510(k) summary or statement. Abbreviated 510(k) does not lower the substantial equivalence bar, does not apply where no recognized reference exists, and is not a shortcut for device changes.
Abbreviated 510(k) is applied standard by standard, not submission by submission. The team maps each performance question to a specific recognition number and edition, files a declaration of conformity for the ones covered, and writes conventional test discussion for the residue. Abbreviated 510(k) submissions fail on that residue, and on standard editions that lapsed before the filing date.
Not to be confused with
- Traditional 510(k)
- the legal requirements and the substantial equivalence test are identical. The only difference is that a Traditional submission discusses each nonclinical and clinical test on its own terms, while an Abbreviated one substitutes a declaration of conformity wherever a recognized reference already answers the question.
- Special 510(k)
- eligibility turns on who holds the prior clearance, not on standards. Special is for a change to a device the same submitter already has cleared; Abbreviated is for demonstrating equivalence to a legally marketed predicate, including someone else's.
- Safety and Performance Based Pathway
- FDA floated this as "Expansion of the Abbreviated 510(k) Program" in the 12 April 2018 draft, then finalized it on 1 February 2019 under its own name. It substitutes FDA-established performance criteria for direct predicate comparison. Abbreviated 510(k) does not; it still rests on a predicate.
- eSTAR
- a submission template and electronic format, not a review pathway. An Abbreviated 510(k) is built in eSTAR like any other 510(k), and choosing eSTAR says nothing about whether you are entitled to declare conformity.
The Abbreviated format changes how performance evidence is presented; it removes none of the statutory content obligations below.
What you must do
- 1Confirm the standard you intend to cite has actually been recognized by FDA through publication in the Federal Register, because the declaration-of-conformity mechanism exists only for recognized standardsFD&C Act 514(c)(1)(A) / 21 U.S.C. 360d(c)(1)(A)
- 2State how the device is similar to and different from other products of comparable type already in commercial distribution, and attach data supporting that statement21 CFR 807.87(f)
- 3Include a 510(k) summary or a 510(k) statement in the submission; the Abbreviated format does not waive it21 CFR 807.87(h)
- 4Discuss in that summary the nonclinical tests submitted, referenced, or relied on, including the ones you reached by declaring conformity rather than by direct comparison21 CFR 807.92(b)(1)
- 5Do not file performance-criteria conformance as an Abbreviated 510(k); FDA moved that approach into a separate pathway when it finalized the guidance on 1 February 2019FR Doc. 2019-00568 (Feb. 1, 2019)
Common mistakes
Declaring conformity to a standard edition FDA no longer recognizes
Recognition is edition-specific and transitions on published dates. A declaration against a superseded edition supports nothing, and the correction arrives as an Additional Information request months into review, by which point the re-testing is on the critical path to launch.
Reading "abbreviated" as less evidence rather than less narrative
The device still has to be as safe and as effective as the predicate, and the 510(k) summary still has to discuss the nonclinical tests relied on. Submissions that declare conformity and stop there get sent back for the data they were always going to owe.
Treating partial standard coverage as full coverage
Partial coverage is the normal case: a standard settles biocompatibility but not the delivery mechanism, or electrical safety but not software. The uncovered questions still need conventional test discussion, and the gap is the first thing a reviewer finds.
When This Matters
- We filed an Abbreviated 510(k) and declared conformity to the recognized biocompatibility standard rather than writing up the cytotoxicity comparison ourselves.
- No recognized reference covers that performance question, so the Abbreviated 510(k) route is closed and we file Traditional.
- The reviewer rejected the Abbreviated 510(k) declaration because we conformed to a superseded edition of the standard.
Frequently Asked Questions
You can file an Abbreviated 510(k) when an FDA-recognized consensus standard, a device-specific special control, or an FDA guidance document covers the performance questions substantial equivalence turns on. If no recognized reference covers those questions, the submission has to carry its own nonclinical and clinical test discussion instead.
Related Use Cases
- Medical Devices Use Cases
Prepare 510(k), PMA, and De Novo submissions with AI-guided pathway selection
- Consulting Use Cases
Manage 15+ client programs from one dashboard with per-client workspaces and tracking
- Regulatory Affairs Workflows
Cut regulatory intelligence tracking from 10+ hours/week to automated, real-time alerts
- Quality/QA Workflows
Track GxP regulation changes and enforcement trends
Related Regulatory Intelligence
Related Actions
Sources & References
- 21 CFR 807.87 - Information required in a premarket notification submission
- 21 CFR 807.92 - Content and format of a 510(k) summary
- FD&C Act Section 514 (21 U.S.C. 360d) - Performance standards and recognition of standards
- Safety and Performance Based Pathway; Guidance for Industry and FDA Staff; Availability (84 FR, Feb. 1, 2019)
